Printer Friendly

High body mass index may cause gallstones.

FROM HEPATOLOGY

An elevated body mass index is not just associated with symptomatic gallstone disease, it appears to cause the disease, according to a new report.

Many epidemiologic and observational studies have noted a clear association between a high BMI and an increased risk for gallstones, but have not been able to pin down a causal effect. It was impossible to rule out confounding by some other factor, such as a high-fat diet, that simultaneously caused both the elevation in BMI and the elevation in risk for gallstones.

Similarly, it was impossible to rule out reverse causation, such as the colicky pain of gallstone disease caused the physical inactivity that then led to a high BMI.

A new epidemiologic statistical approach known as Mendelian randomization is thought to avert both confounding and reverse causation by pinpointing the genetic variants that are linked to a high BMI (which are a constant throughout the lifespan) but that are not related to confounding factors, then determining whether they are also linked to gallstone disease.

"If raised BMI truly is a causal factor in the development of gallstone disease, genetic variants that increase BMI would be expected to also increase risk of gallstone disease," said Dr. Stefan Stender of the department of clinical biochemistry, Rigshospitalet, University of Copenhagen, and his associates (Hepatology 2013 June 14 [doi:10.1002/hep.26563]).

They studied 77,679 Danish adults from the general population who participated in two large prospective studies: the Copenhagen General. Population Study (67,314 subjects) and the Copenhagen City Heart Study (10,365 subjects). All the participants had donated blood samples that could be used for DNA extraction and genotyping.

A total of 4,106 of these subjects developed symptomatic gallstone disease during follow-up of up to 34 years.

The researchers used genotyping to identify study subjects who carried any of the three polymorphisms that have the largest known effect sizes for association with BMI in European populations: FTO (rs9939609), MC4R (rs17782313), or TMEM18 (rs6548238). Each of these can be carried on two possible alleles, so any given subject could carry one to six affected alleles. The number of BMI-increasing from one to six, was determined for each study subject.

In an initial analysis of the data, the mean baseline BMI was 55% higher (11 kg/[m.sup.2]) in subjects carrying the most alleles compared with those carrying the fewest.

Increasing BMI was associated with a stepwise increase in the risk of developing symptomatic gallstone disease.

In the overall cohort, the risk of symptomatic gallstone disease was increased 7% for every 1-kg/[m.sup.2] increase in BMI. In the Mendelian randomization cohort, the risk of gallstone disease increased 17% with every 1-kg/[m.sup.2] increase in BML The concordance between these two estimates indicates that BMI itself is a causal risk factor for symptomatic gallstone disease, Dr. Stender and his associates said.

This study did not include data on gallstone composition and was not designed to examine the pathophysiologic mechanisms by which a high BMI causes gallstone formation. However, numerous other studies have proposed several possible mechanisms, they noted.

Obesity may raise cholesterol synthesis and hepatobiliary cholesterol efflux, "a key event in the development of cholesterol gallstones." High abdominal fat mass may induce gallbladder hypomotility and bile stasis, "another risk factor for gallstone formation."

In addition, substances secreted by or metabolized by adipocytes could influence gallstone formation.

This study was limited in that it included only white people of Danish descent. "Because ethnic differences in gallstone prevalence are well known, the results reported here may not necessarily translate to other ethnicities," Dr. Stender and his colleagues said.

imnews@frontlinemedcom.com

RELATED ARTICLE: VITALS

Major finding: In the overall cohort, the risk of symptomatic gallstone disease was increased 7% for every 1-kg/[m.sup.2] increase in BMI, and in the Mendelian randomization cohort, the risk of gallstone disease increased 17% with every 1-kg/[m.sup.2] increase in BMI.

Data source: A Mendelian randomization study involving 77,679 adults from the Danish general population who were genotyped to identify carriers of three BMI-increasing polymorphisms and who were followed for up to 34 years for the development of symptomatic gallstone disease.

Disclosures: This study was supported by the Danish Medical Research Council, the Rigshospitalet at Copenhagen University, and the Odd Fellow Order. No financial conflicts of interest were reported.
COPYRIGHT 2013 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Moon, Mary Ann
Publication:Internal Medicine News
Date:Aug 1, 2013
Words:727
Previous Article:High-risk smokers benefit most from CT screening.
Next Article:Probiotic Saccharomyces boulardii didn't stop Crohn's return.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |